BOSTON, MA, Breaking, a plastic degradation and synthetic biology company, gestated at Colossal Biosciences based on a core discovery out of the Wyss Institute for Biologically Inspired Engineering at Harvard University, has launched with the announcement of their discovery, X-32, which they will develop to address the global plastics crisis.

Breaking has raised $10.5 million in a seed round prior to this announcement. The company was co-founded by the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University Donald Ingber, world-renowned biotech entrepreneur and Harvard geneticist George Church, CEO Sukanya Punthambaker, CSO Vaskar Gnyawali, Alba Tull, Kent Wakeford, and Ben Lamm.